EUVIMEDEUVIMED entdecken
Crossref

Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy

Liezhi Cao, Qiang Gao, Xiaoming Zuo, Yong Kong, Haiying Chen

New Journal of Chemistry · 2026 · 50 (27) · 11169-11177

DOI: 10.1039/d6nj01310d ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Liezhi Cao und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Hainan Medical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fe-MOF is synthesized and co-encapsulated with doxorubicin in pH-responsive hydrogels for chemotherapy, chemodynamic therapy and photodynamic therapy of breast cancer.

Förderung

  • Hainan Medical University

Zitieren

APA

Cao, L., Gao, Q., Zuo, X., Kong, Y., & Chen, H. (2026). Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy. New Journal of Chemistry, 50(27), 11169-11177. https://doi.org/10.1039/d6nj01310d

Vancouver

Cao L, Gao Q, Zuo X, Kong Y, Chen H. Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy. New Journal of Chemistry. 2026;50(27):11169-11177. doi:10.1039/d6nj01310d

BibTeX
@article{Cao2026,
  author = {Cao, Liezhi and Gao, Qiang and Zuo, Xiaoming and Kong, Yong and Chen, Haiying},
  title = {Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy},
  journal = {New Journal of Chemistry},
  year = {2026},
  volume = {50},
  number = {27},
  pages = {11169--11177},
  doi = {10.1039/d6nj01310d}
}
Kostenlos starten →